Survival Time After RS and hfSRT of Brain Metastases


Gunnar Surber from the Center for Stereotactic Neurosurgery and Radiosurgery at HELIO Clinic in Erfurt, Germany, discusses survival time after the interdisciplinary treatment of brain metastases with radiosurgery and hypofractionated stereotactic radiotherapy. He begins by giving an overview of their treated patient population as well as the treatment strategies employed at his institution for brain mets. He then delves into the prognostic relevant factors and gives a comparison of radiosurgery versus hypofractionated stereotactic radiotherapy including their effects before outlining case reports of specific patients.

About the speaker

Gunnar Surber

Gunnar Surber
Helios Klinikum Erfurt, Germany


Related Videos

  • Control of Brain Metastases in the Eloquent Brain using SRS

    Control of Brain Metastases in the Eloquent Brain using SRS

  • Contrast Clearance Analysis for Differentiating Tumor from Treatment Effects

    Contrast Clearance Analysis for Differentiating Tumor from Treatment Effects

    Dheerendra Prasad, MD
    Roswell Park Comprehensive Cancer Center
    Show video

  • Impact of Margins for Single Isocenter Multiple Target Treatments

    Impact of Margins for Single Isocenter Multiple Target Treatments

    Nzhde Agazaryan, PhD
    University of California Los Angeles, USA
    Show video

  • Paradigm Shift in Management of Intracranial Metastasis: A Review of the First 1,200 Tumors Treated

    Paradigm Shift in Management of Intracranial Metastasis: A Review of the First 1,200 Tumors Treated

    Javad Rahimian, PhD
    Kaiser Permanente Los Angeles Medical Center, USA
    Show video

  • The Future of Indication-Specific Software Automation

    The Future of Indication-Specific Software Automation

    Bogdan Valcu
    Brainlab
    Show video

  • Clinical Advantages of Elements with ExacTrac

    Clinical Advantages of Elements with ExacTrac

    Cory Knill, MS
    Beaumont Health, USA
    Show video

  • Benefits of Implementing Automation and Outcome Measures in Modern Radiosurgery Practices

    Benefits of Implementing Automation and Outcome Measures in Modern Radiosurgery Practices

    Nader Pouratian, MD
    University of California Los Angeles, USA
    Show video

  • Clinical Outcomes for Single Isocenter Treatments in Patients with up to 10 Metastases

    Clinical Outcomes for Single Isocenter Treatments in Patients with up to 10 Metastases

    Giuseppe Minniti, MD, PhD
    Azienda Ospedaliera Sant' Andrea, Roma, Italy
    Show video


Back

Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.

WATCH Video

Keep Watching

Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.

  • Please read the following notice
    I have read the privacy policy. I agree that my information and data will be collected and stored electronically in order to answer my enquiry. Please note: You can revoke your consent at any time with effect for the future by emailing legal@brainlab.com.

Watch video No Thanks

Already Novalis Circle Member?

Member Login

Register now

Thank you for your interest in our Novalis Circle videos. Full-access to the media library is currently available for Novalis Radiosurgery users only. If you are a customer, please register or login to continue.

Register Now Login